Stromal cell-derived factor-1alpha improves infarcted heart function through angiogenesis in mice.

Area of Science:

• Cardiovascular Research
• Regenerative Medicine
• Molecular Biology

Background:

• Local delivery of stromal cell-derived factor-1alpha (SDF-1) enhances neovascularization in limb ischemia models.
• The potential of SDF-1 to promote neovascularization in ischemic heart tissue was investigated.

Purpose of the Study:

• To evaluate the therapeutic effect of local SDF-1 administration on cardiac function and angiogenesis after acute myocardial infarction.
• To assess the contribution of bone marrow cells to SDF-1-mediated angiogenesis in the infarcted heart.

Main Methods:

• Acute myocardial infarction was induced in mice via left coronary artery ligation.
• Mice received direct injection of SDF-1 or saline into the ischemic myocardium.
• Cardiac function, infarct size, and capillary density were assessed; chimeric mice with fluorescently labeled bone marrow cells were used to track cell contribution.

Main Results:

• SDF-1 treatment significantly improved fractional shortening at 4 weeks post-infarction.
• The infarct area was significantly smaller in the SDF-1 treated group compared to controls.
• Capillary vessel density was significantly increased in SDF-1 treated mice, with bone marrow cells found near these vessels.

Conclusions:

• Local SDF-1 administration protects cardiac function following acute myocardial infarction by promoting angiogenesis.
• Further studies are needed to determine the safety and long-term efficacy of SDF-1 treatment for myocardial infarction.